Kansas City Life Insurance (OTCMKTS:KCLI) Posts Quarterly Earnings Results

Key Points

• Kansas City Life Insurance reported quarterly earnings of $0.99 per share, with a negative net margin of 4.54% but a positive return on equity of 2.19%.
• Shares closed down $0.05 at $30.25 on higher-than-average volume (8,002 vs. 1,440), and the company has a market capitalization of $292.8 million with a negative price-to-earnings ratio of -13.27.
• The stock’s technicals show 50- and 200-day moving averages around $32, a 52-week range of $27.45–$36.49, and a low beta of 0.45, indicating subdued volatility.

Kansas City Life Insurance (OTCMKTS:KCLI - Get Free Report) announced its earnings results on Friday. The financial services provider reported $0.99 earnings per share for the quarter, Zacks reports. Kansas City Life Insurance had a negative net margin of 4.54% and a positive return on equity of 2.19%.

Kansas City Life Insurance Stock Performance

Shares of KCLI stock traded down $0.05 on Friday, hitting $30.25. The stock had a trading volume of 8,002 shares, compared to its average volume of 1,440. The firm has a market capitalization of $292.82 million, a price-to-earnings ratio of -13.27 and a beta of 0.45. The stock's 50 day moving average is $32.03 and its 200-day moving average is $32.14. Kansas City Life Insurance has a 52-week low of $27.45 and a 52-week high of $36.49.

About Kansas City Life Insurance

Kansas City Life Insurance Company, trading under the symbol KCLI, is a publicly held life insurer founded in 1895 and headquartered in Kansas City, Missouri. With more than a century of operations, the company has established itself as a provider of life insurance and retirement products across the United States.

The company's core offerings include individual life insurance policies—term life, universal life and whole life—as well as fixed annuities designed to help clients build and preserve wealth.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.